Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 3FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

pembrolizumab 2apalutamide 2abiraterone 2Testosterone 2Radiosurgery 2Leuprolide 2Golytely 2Exercise 2Cryotherapy 2Abiraterone Acetate 2zanubrutinib 1venetoclax 1stenoparib 1relugolix 1olaparib 1nilutamide 1leucoselect phytosome 1ibrutinib 1histrelin 1enzalutamide 1copanlisib 1capivasertib 1bicalutamide 1avelumab 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1acalabrutinib 1Waiting Lists 1Triptorelin Pamoate 1Temozolomide 1Surveys and Questionnaires 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
FED × Testosterone × 1 year × Clear all
NCT06084338 2025-12-31

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

VA Office of Research and Development

Phase 2 Recruiting
60 enrolled
Genitourinary

Prostatic Neoplasms

NCT05011383 2025-07-09

VA-BAT

VA Office of Research and Development

Phase 2 Recruiting
51 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡